Lonza | LONN - Beneficio Operativo

Precio De Mercado
499.10
Cambio Diario
-9.10 -1.79%
Mensual
4.70%
Anual
-11.98%
Q2 Expectativa
532.86




Beneficio Operativo Cambio Fecha
Akzo Nobel EUR 254M 37M 2026-03
Alcon AG USD 313M 19M 2025-12
Almirall EUR 30.23M 12.8M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
BASF EUR -175M 668M 2025-12
Bayer EUR 1.11B 1.65B 2025-12
Beiersdorf EUR 504M 312M 2025-12
Covestro EUR -324M 5.72B 2025-12
Demant DKK 2.09B 224M 2025-12
Fresenius EUR 713M 139M 2025-12
Fresenius Medical Care EUR 663M 213.06M 2025-12
Geberit CHF 134.1M 65.8M 2025-12
Genmab DKK 260M 199M 2025-12
Givaudan CHF 610M 149M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
GN Store Nord DKK 570M 230M 2025-12
Hikma Pharmaceutical USD 348M 161M 2025-12
Johnson Matthey GBP 142M 89M 2025-12
Merck EUR 474M 738M 2025-12
Novartis USD 4.06B 437M 2025-12
Philips EUR 719M 390M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Sanofi EUR 1.94B 239M 2026-03
Sika AG CHF 724.9M 73.2M 2025-12
Smith & Nephew USD 440M 50M 2025-12
Solvay EUR 60M 78M 2025-12
UCB EUR 1.29B 571M 2025-12